Literature DB >> 7695182

Pathophysiology and pathogenesis of visceral fat obesity.

Y Matsuzawa1, I Shimomura, T Nakamura, Y Keno, K Tokunaga.   

Abstract

Based on the analysis of fat distribution by CT scanning, we have proposed a classification of obesity--visceral fat obesity--in which fat accumulation is predominant in the intraabdominal cavity. This type of obesity is more frequently accompanied by disorders of glucose and lipid metabolism and also with hypertension than subcutaneous fat obesity. We also showed that visceral fat obesity was present in almost 90% of obese patients with ischemic heart disease. From clinical and basic experiments, aging imbalance of sex hormone, overintake of sucrose, and lack of physical exercise have been suggested to be major factors for visceral fat accumulation. Since intraabdominal fat (mesenteric and omentum fat) have been shown to have high activities of both lipogenesis and lipolysis, its accumulation induces high contents of free fatty acids, a product of lipolysis, in portal circulation which goes into the liver directly. Excess free fatty acid may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance, and hypertension and finally atherosclerosis.

Entities:  

Mesh:

Year:  1995        PMID: 7695182     DOI: 10.1111/j.1749-6632.1994.tb17336.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 2.  Development of type 2 diabetes in children and adolescents.

Authors:  Ram Weiss; Sara E Taksali; Sonia Caprio
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

3.  Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index.

Authors:  Y Seki; M Ohue; M Sekimoto; S Takiguchi; I Takemasa; M Ikeda; H Yamamoto; M Monden
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

Review 4.  The genetics of fat distribution.

Authors:  Dorit Schleinitz; Yvonne Böttcher; Matthias Blüher; Peter Kovacs
Journal:  Diabetologia       Date:  2014-03-16       Impact factor: 10.122

5.  Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: role of hepatic triglyceride storage.

Authors:  Michelle T Foster; Haifei Shi; Randy J Seeley; Stephen C Woods
Journal:  Physiol Behav       Date:  2011-06-12

6.  Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women.

Authors:  Kijin Kim
Journal:  Eur J Appl Physiol       Date:  2009-01-06       Impact factor: 3.078

7.  Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease.

Authors:  Jose R Medina-Inojosa; John A Batsis; Marta Supervia; Virend K Somers; Randal J Thomas; Sarah Jenkins; Chassidy Grimes; Francisco Lopez-Jimenez
Journal:  Am J Cardiol       Date:  2018-02-02       Impact factor: 2.778

Review 8.  Role of visceral adipose tissue in aging.

Authors:  Derek M Huffman; Nir Barzilai
Journal:  Biochim Biophys Acta       Date:  2009-01-31

9.  Abdominal obesity, independent from caloric intake, accounts for the development of intestinal tumors in Apc(1638N/+) female mice.

Authors:  Derek M Huffman; Leonard H Augenlicht; Xueying Zhang; John J Lofrese; Gil Atzmon; John P Chamberland; Christos S Mantzoros
Journal:  Cancer Prev Res (Phila)       Date:  2013-03

10.  Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations.

Authors:  A M Magnuson; D P Regan; J K Fouts; A D Booth; S W Dow; M T Foster
Journal:  Cell Prolif       Date:  2017-08-01       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.